Three visits. One season.
PitchSight is diagnostic musculoskeletal ultrasound for throwing athletes — imaging that sees the structures inside the elbow in real time. We come to you: convenient, painless, zero radiation. Every package is a full season — pre-season, mid-season, and post-season — because a single scan taken out of context is hard to interpret on its own. What carries information is how your athlete's tissue changes across the year, measured against their own baseline. Each visit pairs the scan with a baseball-specific PT exam, and every athlete gets the Pitch Count Portal to track workload in between.
Pick your level of coverage.
The clinical core is identical in all three. Same visits, same exam, same ultrasound, same RMSK interpretation, same findings report — at every price. The packages differ only on coaching, access, and convenience.
The clinical core. Three visits — pre-season, mid-season, and post-season — each with a dynamic-stress ultrasound, a baseball-specific PT exam, RMSK interpretation, and a written findings report. Includes Pitch Count Portal access with workload tracking.
Get in touch →Everything in Protect, plus an individualized arm-care program built from your athlete's own exam findings and reissued at each visit. Includes the PitchSight Arm Care Kit, a mid-season video check-in, priority scheduling, and an off-season throwing plan.
Get in touch →Everything in Prepare, plus six sessions with a contracted pitching coach working from a clinical directive, a direct line through the season, an upgraded kit, and an end-of-season report that's yours to keep to help guide your future throwing.
Join the waitlist →PitchSight is a screening and decision-support service. It is not a diagnosis and does not replace evaluation by a physician. Screening cannot predict injury — a normal result does not mean an arm cannot be hurt, and a flagged result does not mean an injury is coming. What it produces is information about the tissue three times a season, where families otherwise have pitch counts and the athlete's own account of how the arm feels. Where a finding warrants it, we refer you to a sports-medicine physician or physical therapist. PitchSight is an out-of-pocket service and does not bill insurance. Without a baseline it's harder to tell what's normal for that athlete — so if you'd like a single scan, you can schedule one at The Collective PT & Performance.
What every scan looks at.
UCL integrity at rest and under dynamic valgus stress
Growth plate gap measurement at rest and under valgus stress
Bone contour and early stress signs at the growth plate
Joint swelling or fluid buildup
Flexor tendon stress signs or injury
Track the workload between visits.
The Pitch Count Portal is free and open to any athlete. Log pitches and high-intent throws after each outing and it applies MLB Pitch Smart guidance, tracks acute-vs-chronic workload, and flags when rest is warranted. It holds workload data only — no clinical records. Your findings reports are delivered separately through Carepatron, our HIPAA-secure clinical records system.
Open the Pitch Count Portal →What is Acute:Chronic Workload Ratio (ACWR)?
Acute:Chronic Workload Ratio compares an athlete's recent training load (the past 7 days) to their longer-term average load (their previous 28-day average) to estimate whether they're being pushed too hard, too fast. For throwers, workload can be measured in pitch counts and/or high-intent throws — and a spike in acute load relative to chronic load has been associated with increased injury risk, particularly at the shoulder and elbow. A single high-effort outing is not the problem. The body needs time to adapt, and a sudden jump from a normal week to a much heavier one can outpace it. ACWR gives coaches, parents, and clinicians an early, objective signal — a "yellow flag" — to build in recovery before that mismatch turns into an injury. While ACWR isn't a perfect predictor, it's one useful piece of a bigger monitoring picture — which is why PitchSight pairs workload data with a physical exam and imaging.